Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SWX:SIGN
SWX:SIGNPackaging

Assessing SIG Group (SWX:SIGN) Valuation After Full Year Loss And Weaker Sales

SIG Group (SWX:SIGN) is back in focus after its latest full year results showed sales of €3,248.7 million and a shift from €194.5 million net income to a €87 million net loss. See our latest analysis for SIG Group. The earnings release has come after a mixed stretch for the stock, with a 90 day share price return of 25.65% and a 1 year total shareholder return decline of 31.77%. This suggests recent momentum has improved while longer term returns remain weak as investors reassess the risk...
TSX:CU
TSX:CUIntegrated Utilities

The Bull Case For Canadian Utilities (TSX:CU) Could Change Following A Sharp 2025 Profit Drop - Learn Why

Canadian Utilities Limited has released its full-year 2025 results, reporting sales of C$3,690 million and net income of C$119 million, with basic and diluted earnings per share from continuing operations of C$0.15, all lower than the prior year. The sharp drop in net income and earnings per share versus 2024 highlights a materially weaker profitability profile that could prompt investors to reassess the company’s earnings resilience. Against this backdrop of significantly lower annual...
BME:EBRO
BME:EBROFood

Ebro Foods’ Rising EPS Amid Softer Sales Could Be A Game Changer For Ebro Foods (BME:EBRO)

Ebro Foods, S.A. has released its full-year 2025 results, reporting sales of €3.01 billion versus €3.14 billion a year earlier, while net income rose to €214.88 million and basic earnings per share from continuing operations increased to €1.397. The combination of lower sales but higher net income and earnings per share suggests Ebro Foods improved profitability and efficiency over the period. We’ll now examine how Ebro Foods’ ability to grow earnings per share despite softer sales...
TSX:ELF
TSX:ELFInsurance

Does The Low P/E Of E‑L Financial (TSX:ELF) Reflect Its Recent Share Price Pullback?

If you are wondering whether E L Financial's share price still reflects its underlying worth, this article will walk through what the current numbers may be telling you about value. The stock has seen mixed recent returns, with a 1.9% decline over the last week, a 7.7% decline over the last month, a 4.3% decline year to date, but a 23.0% return over the past year and very large gains over three and five years of about 1.2x and 1.6x respectively. Recent coverage around E L Financial has...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Zevra Therapeutics (ZVRA) Profit Swing To US$77.6m TTM Tests Rare Disease Bull Case

Zevra Therapeutics (ZVRA) has wrapped up FY 2025 with Q4 total revenue of US$34.1 million and basic EPS of US$0.21, while trailing twelve month figures show total revenue of US$106.5 million and basic EPS of US$1.40. Over the past year, the company has seen total revenue move from US$23.6 million on a trailing basis in Q4 2024 to US$106.5 million by Q4 2025, alongside a shift from a trailing net loss of US$105.5 million to trailing net income of US$77.6 million. This sets the stage for a more...
NZSE:AIR
NZSE:AIRAirlines

Air New Zealand (NZSE:AIR) Valuation Check After Half Year Net Loss And Scrapped Interim Dividend

Air New Zealand (NZSE:AIR) is back in focus after reporting a net loss of NZ$40 million for the half year to December 31, 2025, and announcing no interim dividend for the period. See our latest analysis for Air New Zealand. The weak half-year result and the decision to skip an interim dividend sit alongside a 1 day share price return of 1.08% decline and a 1 year total shareholder return of 25.44% decline, pointing to fading momentum rather than a short-term wobble. If this kind of setback...
TSX:CCA
TSX:CCATelecom

Is It Time To Reassess Cogeco Communications (TSX:CCA) After Recent Share Price Rebound

If you are wondering whether Cogeco Communications is still reasonably priced or already fully valued, you are not alone. This article is built to help you frame that question clearly. The share price sits at C$72.10 after a 1.3% decline over the last week, with returns of 8.2% over 30 days, 7.4% year to date, 13.9% over 1 year, 39.9% over 3 years and a 24.2% decline over 5 years that longer term holders will be very aware of. These mixed returns have come alongside ongoing sector and...
TSE:7832
TSE:7832Leisure

Should Dividend Cut And Potential Buybacks Prompt A Fresh Look At BANDAI NAMCO (TSE:7832)?

BANDAI NAMCO Holdings Inc. previously reported nine-month results to December 31, 2025, with sales of ¥1,002,243 million and net income of ¥115,044 million, while also cutting full-year dividend guidance for the year ending March 31, 2026 to ¥50 per share from ¥60 a year earlier. Alongside these updates, the board scheduled a March 6, 2026 meeting to consider purchasing treasury shares, highlighting an active approach to capital allocation despite reduced shareholder payouts. We’ll now...
TSE:5831
TSE:5831Banks

Assessing Shizuoka Financial Group (TSE:5831) Valuation After ¥300b Bond Shelf Registration

Shizuoka Financial GroupInc (TSE:5831) is back in focus after a recent shelf registration for up to ¥300b in bonds, together with a board meeting to consider acquiring treasury stock and other capital management items. See our latest analysis for Shizuoka Financial GroupInc. The bond shelf registration and planned treasury stock discussions come after a mixed few weeks for the share price. A 4.06% 1 day share price return contrasts with a 6.58% 7 day decline and an 8.22% year to date gain...
BIT:AZM
BIT:AZMCapital Markets

Assessing Azimut Holding (BIT:AZM) Valuation After Record Inflows Strong Profit Beat And Higher Dividend

Azimut Holding (BIT:AZM) is back in focus after reporting full year 2025 results that exceeded market expectations on net profit and announcing a higher annual dividend of €2.00 per share. See our latest analysis for Azimut Holding. The strong earnings and dividend news has arrived after a mixed run for the share price, with a 4.81% 1 day share price return and a 6.19% 1 month share price decline, alongside a 1 year total shareholder return of 45.26% and very strong multi year total...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

How New CHMP Opinions on Dupixent and Acoziborole Will Impact Sanofi (ENXTPA:SAN) Investors

In late February 2026, Sanofi and Regeneron reported that the European Medicines Agency’s CHMP issued positive opinions for Dupixent in young children with chronic spontaneous urticaria and for Acoziborole Winthrop as a single-dose oral treatment for gambiense sleeping sickness, with final EU decisions expected in the months that followed. These CHMP endorsements highlight how Sanofi’s immunology and neglected tropical disease programs may broaden its treatment footprint across both...
SEHK:2
SEHK:2Electric Utilities

Assessing CLP Holdings (SEHK:2) Valuation After Weaker 2025 Results And New Fourth Interim Dividend

CLP Holdings (SEHK:2) is back in focus after releasing its full year 2025 results. The company reported lower sales and net income year on year and declared a fourth interim dividend of HK$1.31 per share. See our latest analysis for CLP Holdings. At a share price of HK$74.75, CLP Holdings has delivered a 10.82% 90 day share price return and a 21.83% 1 year total shareholder return, suggesting momentum has been rebuilding recently despite softer reported earnings. If this earnings and dividend...
TSE:8411
TSE:8411Banks

How New Perpetual Subordinated Notes, Buybacks And Governance Shift At Mizuho (TSE:8411) Has Changed Its Investment Story

Mizuho Financial Group has recently completed the issuance of two tranches of fixed-to-floating rate perpetual, subordinated, unsecured notes totaling ¥190 billion, alongside board approval to repurchase common stock and an extensive refresh of its senior leadership and board structure. This combination of new subordinated capital and leadership reshaping highlights an effort to refine the group’s capital structure and governance framework at the same time. We’ll now examine how the new...
NYSE:RNG
NYSE:RNGSoftware

RingCentral AIR Pro Launch Puts AI Healthcare Agents In Investor Focus

RingCentral has launched RingCentral AIR Pro, an AI powered, voice first omnichannel agent platform. The platform offers a no code environment for building and deploying digital agents across channels. AIR Pro debuts with healthcare focused capabilities, including support for integrations with major electronic health record systems. RingCentral, traded as NYSE:RNG, is introducing AIR Pro at a time when its shares trade around $40.69. The stock has seen strong recent momentum, with returns...
TSE:6856
TSE:6856Electronic

Assessing HORIBA (TSE:6856) Valuation As Activist Oasis Challenges Governance And Pushes For Change

Activist pressure puts HORIBA in the spotlight Oasis Management, which owns 9.90% of HORIBA (TSE:6856), has urged shareholders to vote against the reappointment of Chairman Atsushi Horiba at the 2026 AGM, sharply criticizing past acquisitions and governance. See our latest analysis for HORIBA. The activist campaign lands at a time when HORIBA’s share price has shown strong momentum, with a 21.6% 90 day share price return and a 100.3% 1 year total shareholder return pointing to shifting...
NYSE:YALA
NYSE:YALAInteractive Media and Services

Yalla Group (YALA) Margins Above 40% Challenge Market Skepticism On Slower Growth Guidance

Yalla Group (YALA) has rounded out FY 2025 with fourth quarter revenue of about US$83.9 million and basic EPS of US$0.23, against a trailing twelve month EPS of US$0.96 that sits alongside earnings growth of 10.4% year on year. Over the past six quarters in the dataset, revenue has moved within a tight band between roughly US$83.9 million and US$90.8 million per quarter, while quarterly EPS has ranged from about US$0.20 to US$0.27, feeding into a trailing net profit margin of 43.8% that is...
ENXTBR:SYENS
ENXTBR:SYENSChemicals

Will Weaker Results, Steady Dividend and Board Shake-Up Change Syensqo's (ENXTBR:SYENS) Narrative?

Syensqo SA has recently reported weaker fourth-quarter and full-year 2025 results, announced an annual dividend of €1.1340 per share for payment on 18 May 2026, redeemed €500,000,000 of 2.750% fixed-rate bonds early, and confirmed several Board changes including appointing Heike van de Kerkhof as independent Chair. These moves combine pressure on profitability with balance sheet reshaping and refreshed governance, giving investors a complex mix of cost, capital allocation and oversight...
ENXTAM:VLK
ENXTAM:VLKCapital Markets

Van Lanschot Kempen (ENXTAM:VLK) Valuation After Higher 2025 Earnings And New Dividend Announcement

Why Van Lanschot Kempen’s latest earnings and dividend matter for shareholders Van Lanschot Kempen (ENXTAM:VLK) reported full year 2025 earnings alongside a fresh dividend announcement. This combination gives you new information on both the bank’s profitability profile and its approach to returning cash to shareholders. See our latest analysis for Van Lanschot Kempen. Investors appear to be reacting to the earnings and dividend news, with a 1-day share price return of 3.96% at a latest price...
NYSE:KRO
NYSE:KROChemicals

Kronos Worldwide (KRO) Q4 Loss Deepens To US$0.72 EPS And Tests Profit-Recovery Hopes

Kronos Worldwide (KRO) closed out FY 2025 with Q4 revenue of US$418.3 million and a basic EPS loss of US$0.72, capping off a trailing twelve month period where revenue totaled US$1.9 billion and basic EPS came in at a loss of US$0.96. Over recent quarters, the company has seen revenue move from US$423.1 million and basic EPS of a US$0.11 loss in Q4 2024 to US$489.8 million with EPS of US$0.16 in Q1 2025, before stepping down to US$456.9 million and a US$0.32 loss in Q3 2025 and ending at...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Is There Now An Opportunity In Ambarella (AMBA) After Recent Share Price Weakness

If you are wondering whether Ambarella's current share price offers value or just more volatility, you are not alone and this article is here to help you weigh that up clearly. The stock last closed at US$54.00, with returns of a 4.5% decline over 7 days, a 17.2% decline over 30 days, a 28.2% decline year to date, a 3.8% gain over 1 year, a 29.5% decline over 3 years and a 51.2% decline over 5 years. Taken together, this gives you a mixed picture of short term pressure and longer term swings...
NasdaqGS:MGNX
NasdaqGS:MGNXBiotechs

MacroGenics (MGNX) Loss Of US$74.6 Million Tests Bullish Loss‑Narrowing Narrative

MacroGenics (MGNX) has wrapped up FY 2025 with fourth quarter revenue of US$41.2 million and a basic EPS loss of US$0.22, as the market weighs these results against a share price of US$3.43. The company has seen revenue move from US$110.7 million in Q3 2024 to US$72.8 million in Q3 2025, while basic EPS shifted from a profit of US$0.90 to a profit of US$0.27 over the same period, creating a mixed picture on topline scale and per share results. Overall, margins remain under pressure, which...
NasdaqCM:IRD
NasdaqCM:IRDBiotechs

Opus Genetics (IRD) Trailing US$49.6m Loss Reinforces Bearish Profitability Narrative

Opus Genetics (IRD) has reported FY 2025 results with Q4 revenue of US$3.9 million, a basic EPS loss of US$0.21, and a net income loss of US$16.5 million. The trailing twelve month figures show revenue of US$14.2 million, a basic EPS loss of US$0.80, and a net income loss of US$49.6 million. Over the recent quarters in FY 2025, the company has reported revenue between US$2.9 million and US$4.4 million, while quarterly basic EPS losses have ranged from US$0.12 to US$0.25 per share. These...
NasdaqGS:GLRE
NasdaqGS:GLREInsurance

Greenlight Capital Re (GLRE) Q4 Combined Ratio Of 92.1% Tests Underwriting Quality Narratives

Greenlight Capital Re (GLRE) has wrapped up FY 2025 with fourth quarter revenue of US$210.5 million and basic EPS of US$1.47, capping a trailing 12 month period that delivered EPS of US$2.21 on revenue of US$721.3 million. Over the last few quarters, revenue has ranged from US$148.1 million to US$210.5 million, while quarterly EPS has swung between a loss of US$0.13 and a profit of US$1.47. This gives investors a fuller picture of how the year built to the latest result. With a trailing net...
NYSE:DLX
NYSE:DLXCommercial Services

Deluxe Board Change Raises Questions For Payments And Cloud Transition

Deluxe (NYSE:DLX) has announced that Director Cheryl E. Mayberry McKissack will step down from its board and will not stand for re election. The board change is scheduled to take effect at the company’s upcoming annual meeting. For shareholders watching Deluxe, a company involved in payments, cloud, and data driven marketing services, board composition is one of the levers that can influence long term priorities. As the broader payments and business services space continues to evolve,...